Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1973 1
1974 1
1978 1
1982 1
1989 1
1991 1
1994 1
1997 1
2000 1
2004 1
2005 1
2006 1
2007 2
2008 4
2009 7
2010 4
2011 7
2012 6
2014 3
2016 2
2017 1
2018 1
2020 2
2021 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.
Morris MJ, Rowe SP, Gorin MA, Saperstein L, Pouliot F, Josephson D, Wong JYC, Pantel AR, Cho SY, Gage KL, Piert M, Iagaru A, Pollard JH, Wong V, Jensen J, Lin T, Stambler N, Carroll PR, Siegel BA; CONDOR Study Group. Morris MJ, et al. Among authors: josephson d. Clin Cancer Res. 2021 Jul 1;27(13):3674-3682. doi: 10.1158/1078-0432.CCR-20-4573. Epub 2021 Feb 23. Clin Cancer Res. 2021. PMID: 33622706 Free PMC article. Clinical Trial.
Kidney cancer.
Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Carducci MA, Chang SS, Choueiri TK, Hancock SL, Hudes GR, Jonasch E, Josephson D, Kuzel TM, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Spiess PE, Wang J, Wilder RB; National Comprehensive Cancer Network. Motzer RJ, et al. Among authors: josephson d. J Natl Compr Canc Netw. 2011 Sep 1;9(9):960-77. doi: 10.6004/jnccn.2011.0082. J Natl Compr Canc Netw. 2011. PMID: 21917622 No abstract available.
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
Surasi DS, Eiber M, Maurer T, Preston MA, Helfand BT, Josephson D, Tewari AK, Somford DM, Rais-Bahrami S, Koontz BF, Bostrom PJ, Chau A, Davis P, Schuster DM, Chapin BF; LIGHTHOUSE Study Group. Surasi DS, et al. Among authors: josephson d. Eur Urol. 2023 Oct;84(4):361-370. doi: 10.1016/j.eururo.2023.06.018. Epub 2023 Jul 5. Eur Urol. 2023. PMID: 37414702 Free article.
New therapies for castrate-resistant prostate cancer.
Williams SB, Lay AH, Lau CS, Josephson DY, Wilson TG, Choueiri TK, Pal SK. Williams SB, et al. Among authors: josephson dy. Expert Opin Pharmacother. 2011 Sep;12(13):2069-74. doi: 10.1517/14656566.2011.590133. Epub 2011 Jun 11. Expert Opin Pharmacother. 2011. PMID: 21663529 Review.
Superficial bladder cancer: part 2. Management.
Josephson D, Pasin E, Stein JP. Josephson D, et al. Expert Rev Anticancer Ther. 2007 Apr;7(4):567-81. doi: 10.1586/14737140.7.4.567. Expert Rev Anticancer Ther. 2007. PMID: 17428176 Review.
Lymphadenectomy in bladder cancer: a review.
Buscarini M, Josephson DY, Stein JP. Buscarini M, et al. Among authors: josephson dy. Urol Int. 2007;79(3):191-9. doi: 10.1159/000107949. Urol Int. 2007. PMID: 17940349 Free article. Review.
51 results